La Jolla Institute For Allergy & Immunology

La Jolla Institute For Allergy & Immunology

La Jolla Institute for Immunology is a non-profit research organization located in La Jolla, San Diego, California. The institute was founded in 1988. It is located in UC San Diego’s Research Park. The institute researches immunology and immune system diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for La Jolla Institute For Allergy & Immunology, United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

74%


Total
Publications

4.5K


Total Open
Publications

3.3K


Total
Citations

334K


Open Access
Percentage

74%


Total
Publications

4.5K


Total Open
Publications

3.3K


Total
Citations

334K

Wikipedia

Website

download

Breakdown

13% 43% 18% 26%

Publisher Open

13%

Both

43%

Other Platform Open

18%

Closed

26%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

726

Hybrid 26%

668

No Guarantees 45%

1.1K

Other Platform Open

Domain 89%

2.4K

Institution 22%

595

Preprint 13%

360

Other Internet 12%

342

Public 8%

228

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
2.4K
Europe PMC
Domain
1.7K
bioRxiv
Preprint
250
DOI
Other Internet
233
Semantic Scholar
Public
197
California Digital Library - eScholarship
Other Internet
134
University of California - eScholarship University of California
Institution
98
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit
Institution
86
medRxiv
Preprint
67
University of Southampton - ePrints Soton
Institution
61
1 / 20

Data updated 17 June 2024

Share

Share

Share